The FDA said it does not intend to take action against 503B drug compounders for 90 days, or until May 22, “to avoid unnecessary disruption to patient treatment.” Hims & Hers Chief Executive Officer ...

Discover how this diabetes drug is revolutionizing heart health. Learn about its surprising benefits in reducing cardiovascular risks and mortality.

An infant with a fatal genetic disease has survived past the age of 2 with no signs of the condition, thanks to treatment started in the womb.